Alexander W. Macfarlane

1.3k total citations
30 papers, 940 citations indexed

About

Alexander W. Macfarlane is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Alexander W. Macfarlane has authored 30 papers receiving a total of 940 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 10 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Alexander W. Macfarlane's work include Immune Cell Function and Interaction (14 papers), T-cell and B-cell Immunology (9 papers) and Immune cells in cancer (7 papers). Alexander W. Macfarlane is often cited by papers focused on Immune Cell Function and Interaction (14 papers), T-cell and B-cell Immunology (9 papers) and Immune cells in cancer (7 papers). Alexander W. Macfarlane collaborates with scholars based in United States, Russia and France. Alexander W. Macfarlane's co-authors include Kerry S. Campbell, Essel Dulaimi, Tahseen Al‐Saleem, Samuel Litwin, Adam D. Cohen, Elizabeth R. Plimack, Gary R. Hudes, Robert G. Uzzo, Robert Stanley and Kathleen S. Christine and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Alexander W. Macfarlane

29 papers receiving 931 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander W. Macfarlane United States 15 534 432 219 117 89 30 940
Stefan Knackmuss Germany 23 485 0.9× 660 1.5× 534 2.4× 168 1.4× 97 1.1× 41 1.4k
Nadja Zaborsky Austria 18 386 0.7× 336 0.8× 283 1.3× 138 1.2× 102 1.1× 49 945
Eva Hellqvist Sweden 9 497 0.9× 249 0.6× 313 1.4× 157 1.3× 68 0.8× 14 964
Shamaila Munir Ahmad Denmark 18 514 1.0× 422 1.0× 171 0.8× 41 0.4× 86 1.0× 29 790
Nicole M. McLaughlin Australia 12 925 1.7× 779 1.8× 318 1.5× 39 0.3× 72 0.8× 12 1.5k
Klaus Brischwein Germany 17 582 1.1× 1.1k 2.5× 451 2.1× 123 1.1× 85 1.0× 21 1.5k
Kimberley Stannard Australia 16 1.1k 2.1× 941 2.2× 426 1.9× 48 0.4× 105 1.2× 17 1.6k
W Zhang United States 13 225 0.4× 437 1.0× 550 2.5× 84 0.7× 144 1.6× 19 1.0k
Evelina Martinenaite Denmark 17 450 0.8× 338 0.8× 176 0.8× 32 0.3× 74 0.8× 33 734
Dirk Zboralski United States 13 218 0.4× 503 1.2× 332 1.5× 26 0.2× 135 1.5× 22 937

Countries citing papers authored by Alexander W. Macfarlane

Since Specialization
Citations

This map shows the geographic impact of Alexander W. Macfarlane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander W. Macfarlane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander W. Macfarlane more than expected).

Fields of papers citing papers by Alexander W. Macfarlane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander W. Macfarlane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander W. Macfarlane. The network helps show where Alexander W. Macfarlane may publish in the future.

Co-authorship network of co-authors of Alexander W. Macfarlane

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander W. Macfarlane. A scholar is included among the top collaborators of Alexander W. Macfarlane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander W. Macfarlane. Alexander W. Macfarlane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Macfarlane, Alexander W., Yinfei Tan, Edna Cukierman, et al.. (2024). Derivation of human primary prostate epithelial cell lines by differentially targeting the CDKN2A locus along with expression of hTERT. Scientific Reports. 14(1). 20409–20409. 1 indexed citations
2.
Ford, Jill, Marieli Gonzalez-Cotto, Alexander W. Macfarlane, et al.. (2022). Tumor-Infiltrating Myeloid Cells Co-Express TREM1 and TREM2 and Elevated TREM-1 Associates With Disease Progression in Renal Cell Carcinoma. Frontiers in Oncology. 11. 662723–662723. 30 indexed citations
3.
Varshavsky, Asya, Alexander W. Macfarlane, Laura Barreyro, et al.. (2022). Lymphocyte Exhaustion in AML Patients and Impacts of HMA/Venetoclax or Intensive Chemotherapy on Their Biology. Cancers. 14(14). 3352–3352. 11 indexed citations
4.
Macfarlane, Alexander W., R. Katherine Alpaugh, Essel Dulaimi, et al.. (2021). Impacts of pembrolizumab therapy on immune phenotype in patients with high-grade neuroendocrine neoplasms. Cancer Immunology Immunotherapy. 70(7). 1893–1906. 8 indexed citations
5.
Macfarlane, Alexander W., et al.. (2021). NK Cells of Acute Myeloid Leukemia Patients Exhibit Exhausted Phenotype with Impaired Functional Activity. Blood. 138(Supplement 1). 4466–4466. 1 indexed citations
6.
Pazina, Tatiana, Alexander W. Macfarlane, Essel Dulaimi, et al.. (2021). Alterations of NK Cell Phenotype in the Disease Course of Multiple Myeloma. Cancers. 13(2). 226–226. 50 indexed citations
7.
Fernandez, Sandra V., Alexander W. Macfarlane, Maria F. Arisi, et al.. (2020). Immune phenotype of patients with stage IV metastatic inflammatory breast cancer. Breast Cancer Research. 22(1). 134–134. 17 indexed citations
8.
Barta, Stefan K., Jasmine Zain, Alexander W. Macfarlane, et al.. (2019). Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 19(6). 356–364.e3. 90 indexed citations
9.
Wagner, Jessica, C. Leah B. Kline, Lanlan Zhou, et al.. (2018). Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment. Journal of Clinical Investigation. 128(6). 2325–2338. 55 indexed citations
10.
Kaileh, Mary, Alexander W. Macfarlane, Kerry S. Campbell, et al.. (2016). mTOR-Dependent and Independent Survival Signaling by PI3K in B Lymphocytes. PLoS ONE. 11(1). e0146955–e0146955. 6 indexed citations
11.
Ge, Moyar Q., Cameron H. Flayer, Sarah S. Killingbeck, et al.. (2015). Cutting Edge: Role of NK Cells and Surfactant Protein D in Dendritic Cell Lymph Node Homing: Effects of Ozone Exposure. The Journal of Immunology. 196(2). 553–557. 18 indexed citations
12.
Macfarlane, Alexander W., Elizabeth R. Plimack, Gary R. Hudes, et al.. (2013). PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor Resection. Cancer Immunology Research. 2(4). 320–331. 141 indexed citations
13.
Macfarlane, Alexander W., et al.. (2012). Immune Cell Dysfunction in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL). Blood. 120(21). 3875–3875. 2 indexed citations
14.
Ni, Minjian, et al.. (2011). B-cell adaptor for PI3K (BCAP) negatively regulates Toll-like receptor signaling through activation of PI3K. Proceedings of the National Academy of Sciences. 109(1). 267–272. 66 indexed citations
15.
Macfarlane, Alexander W., et al.. (2009). Measuring Intracellular Calcium Signaling in Murine NK Cells by Flow Cytometry. Methods in molecular biology. 612. 149–157. 10 indexed citations
16.
Macfarlane, Alexander W., Tetsuo Yamazaki, Min Fang, et al.. (2008). Enhanced NK-cell development and function in BCAP-deficient mice. Blood. 112(1). 131–140. 27 indexed citations
17.
Franzen, Stefan, Audrius Jasaitis, Jennifer Belyea, et al.. (2006). Hydrophobic Distal Pocket Affects NO−Heme Geminate Recombination Dynamics in Dehaloperoxidase and H64V Myoglobin. The Journal of Physical Chemistry B. 110(29). 14483–14493. 13 indexed citations
18.
Macfarlane, Alexander W. & Kerry S. Campbell. (2005). Signal Transduction in Natural Killer Cells. Current topics in microbiology and immunology. 298. 23–57. 82 indexed citations
19.
Christine, Kathleen S., et al.. (2002). Cyclobutylpyrimidine Dimer Base Flipping by DNA Photolyase. Journal of Biological Chemistry. 277(41). 38339–38344. 59 indexed citations
20.
Graham, Ruth M., et al.. (1987). β2 Microglobulin expression in keratoacanthomas and squamous cell carcinoma. British Journal of Dermatology. 117(4). 441–449. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefan Knackmuss Breakdown of academic impact, for papers by Nadja Zaborsky Breakdown of academic impact, for papers by Eva Hellqvist Breakdown of academic impact, for papers by Shamaila Munir Ahmad Breakdown of academic impact, for papers by Nicole M. McLaughlin Breakdown of academic impact, for papers by Klaus Brischwein Breakdown of academic impact, for papers by Kimberley Stannard Breakdown of academic impact, for papers by W Zhang Breakdown of academic impact, for papers by Evelina Martinenaite Breakdown of academic impact, for papers by Dirk Zboralski
Rankless by CCL
2026